Verition Fund Management LLC 10x Genomics, Inc. Transaction History
Verition Fund Management LLC
- $16.5 Billion
- Q2 2024
A detailed history of Verition Fund Management LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 10,970 shares of TXG stock, worth $175,849. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,970Holding current value
$175,849% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding TXG
# of Institutions
283Shares Held
97.2MCall Options Held
162KPut Options Held
107K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$172 Million2.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$163 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$102 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.15MShares$98.6 Million1.4% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.14MShares$98.5 Million0.09% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.52B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...